Prof. Bapat completed his medical education in Mumbai, India and then in Canada and UK. After completing Fellowship in Toronto General hospital in 1999, he moved to UK and completed Cardiothoracic training in UK and obtained FRCS.CTh in 2005. He was appointed as a consultant at the Guys and St. Thomas’ hospital in 2007 with special interest in aortic surgery.
He was the surgical lead for the Transcatheter Aortic Valve Implantation (TAVI) program at St. Thomas’ Hospital, which is the largest TAVI program in UK and acts as a tertiary referral center for complex TAVI cases. He pioneered new methods of performing TAVI (trans-aortic approach), led the original research and guidance on valve-in-valve indication and has developed smartphone Apps, which are used all over the world as a reference tool for valve-in-valve. He also leads research in advance indications of TAVR such as MAC. Dr. Bapat has trained over 100 centers in TAVI all over the world and continues to participate actively in teaching and training on all aspects of TAVI.
He has been involved in early feasibility study of the Transcatheter mitral valve implantation and has performed first-in-man implant of Edward’s FORTIS device in February 2014 and also of Medtronic’s Intrepid device prior to its acquisition. He was the PI for the global feasibility trial investigating Intrepid device.
Similarly, he has led bench and clinical application of newer tricuspid replacement and repair devices such as Navigate, Intrepid and Tricinch.
Prof. Bapat has a large research and innovation program to help advance the field and has over 150 publications. He is an invited faculty for all major cardiology and cardiac surgical meeting. Prof. Bapat moved to Columbia University Medical Center in New York three years ago and is the lead for advance Mitral and Tricuspid therapy. In June 2020 he accepted the appointment at the Abbott Northwestern Hospital and Minneapolis Heart Institution as Chief of Cardiothoracic Surgery.